Atovacue TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: atovaquone
Pack: Atovacue 750 mg/5 mL oral liquid, 210 mL, bottle
Brand name
(ARTG)
: ATOVACUE atovaquone 750 mg/5 mL oral liquid suspension bottleDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
ATOVACUE oral suspension is indicated for:,Acute treatment of mild to moderate Pneumocystis carinii pneumonia (PCP) (difference of alveolar and arterial oxygen tensions [(A-a) DO2] =45 mmHg (6 kPa) and oxygen tension in arterial blood (Pa02) =60 mmHg (8 kPa) breathing room air) in adult patients with AIDS who are intolerant of trimethoprim/sulfamethoxazole therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Oral Liquid, suspension
- Oral
- Bright yellow liquid with a sweet, fruity odour.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Do not Refrigerate
- Shelf lifetime is 24 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 x 210 mL bottle, 1 x measuring spoon pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient atovaquone
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
